201. Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR‐1‐dependent pathway
- Author
-
Michele D'Amico, Iacopo Panarese, Maria Consiglia Trotta, Eliana Gulotta, Gorizio Pieretti, Giovanni Francesco Nicoletti, Bartolo Ferraro, Antonietta Messina, Trotta, M. C., Ferraro, B., Messina, A., Panarese, I., Gulotta, E., Nicoletti, G. F., D'Amico, M., and Pieretti, Gorizio
- Subjects
Male ,0301 basic medicine ,Cell Survival ,Myocardial Infarction ,Ischemia ,Connexin ,Myocardial Reperfusion Injury ,Pharmacology ,miR‐1 ,telmisartan ,Cell Line ,connexin 43 ,Rats, Sprague-Dawley ,hypoxic H9c2 cells ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,medicine ,Animals ,Bcl-2 ,Myocytes, Cardiac ,KCNQ1 ,Chemistry ,Bcl‐2 ,Original Articles ,Cell Biology ,Transfection ,Hypoxia (medical) ,medicine.disease ,miR-1 ,Cell Hypoxia ,In vitro ,Rats ,MicroRNAs ,myocardial ischaemia/reperfusion ,030104 developmental biology ,Proto-Oncogene Proteins c-bcl-2 ,030220 oncology & carcinogenesis ,KCNQ1 Potassium Channel ,Molecular Medicine ,hypoxic H9c2 cell ,Original Article ,medicine.symptom ,Telmisartan ,Reperfusion injury ,medicine.drug - Abstract
The aim of this study was to investigate whether telmisartan protects the heart from the ischaemia/reperfusion damage through a local microRNA-1 modulation. Studies on the myocardial ischaemia/reperfusion injury in vivo and on the cardiomyocyte hypoxia/reoxygenation damage in vitro were done. In vivo, male Sprague-Dawley rats administered for 3weeks with telmisartan 12mg/kg/d by gastric gavage underwent ischaemia/reperfusion of the left descending coronary artery. In these rats, infarct size measurement, ELISA, immunohistochemistry (IHC) and reverse transcriptase real-time polymerase chain reaction showed that expressions of connexin 43, potassium voltage-gated channel subfamily Q member 1 and the protein Bcl-2 were significantly increased by telmisartan in the reperfused myocardium, paralleled by microRNA-1 down-regulation. In vitro, the transfection of cardiomyocytes with microRNA-1 reduced the expressions of connexin 43, potassium voltage-gated channel subfamily Q member 1 and Bcl-2 in the cells. Telmisartan (50µmol/L) 60minutes before hypoxia/reoxygenation, while not affecting the levels of miR-1 in transfected cells in normoxic condition, almost abolished the increment of miR-1 induced by the hypoxia/reoxygenation to transfected cells. All together, telmisartan cardioprotected against the myocardial damage through the microRNA-1 modulation, and consequent modifications of its downstream target connexin 43, potassium voltage-gated channel subfamily Q member 1 and Bcl-2. The aim of this study was to investigate whether telmisartan protects the heart from the ischaemia/reperfusion damage through a local microRNA-1 modulation. Studies on the myocardial ischaemia/reperfusion injury in vivo and on the cardiomyocyte hypoxia/reoxygenation damage in vitro were done. In vivo, male Sprague-Dawley rats administered for 3 weeks with telmisartan 12 mg/kg/d by gastric gavage underwent ischaemia/reperfusion of the left descending coronary artery. In these rats, infarct size measurement, ELISA, immunohistochemistry (IHC) and reverse transcriptase real-time polymerase chain reaction showed that expressions of connexin 43, potassium voltage-gated channel subfamily Q member 1 and the protein Bcl-2 were significantly increased by telmisartan in the reperfused myocardium, paralleled by microRNA-1 down-regulation. In vitro, the transfection of cardiomyocytes with microRNA-1 reduced the expressions of connexin 43, potassium voltage-gated channel subfamily Q member 1 and Bcl-2 in the cells. Telmisartan (50 µmol/L) 60 minutes before hypoxia/reoxygenation, while not affecting the levels of miR-1 in transfected cells in normoxic condition, almost abolished the increment of miR-1 induced by the hypoxia/reoxygenation to transfected cells. All together, telmisartan cardioprotected against the myocardial damage through the microRNA-1 modulation, and consequent modifications of its downstream target connexin 43, potassium voltage-gated channel subfamily Q member 1 and Bcl-2.
- Published
- 2019